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Abstract  
Iron plays a significant role in the body, and is specifically important to athletes, since it is a 
dominant feature in processes such as oxygen transport and energy metabolism. Despite its 
importance, athlete populations, especially females and endurance athletes, are commonly 
diagnosed with iron deficiency, suggesting an association between sport performance and iron 
regulation. Although iron deficiency is most common in female athletes (~15-35% athlete 
cohorts deficient), approximately 5-11% of male athlete cohorts also present with this issue. 
Furthermore, interest has grown in the mechanisms that influence iron absorption in athletes 
over the last decade, with the link between iron regulation and exercise becoming a research 
focus. Specifically, exercise-induced increases in the master iron regulatory hormone, 
hepcidin, has been highlighted as a contributing factor towards altered iron metabolism in 
athletes. To date, a plethora of research has been conducted, including investigation into the 
impact that sex hormones, diet (e.g. macronutrient manipulation), training and environmental 
stress (e.g. hypoxia due to altitude training) have on an athlete’s iron status, with numerous 
recommendations proposed for consideration. This review summarises the current state of 
research with respect to the aforementioned factors, drawing conclusions and 
recommendations for future work. 
 
Key words: Iron deficiency, Anemia, Hepcidin, Exercise  
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Change in Hemoglobin Mass (ΔHbmass) 
Divalent Metal Transporter 1 (DMT-1)  
Duodenal Cytochrome b (DCytB) 
Erythroferrone (ERFE) 
Erythropoietin (EPO) 
Follicle Stimulating Hormone (FSH) 
Gastro-Intestinal (GI) 
Hemoglobin (Hb) 
Hemoglobin mass (Hbmass) 
Hypoxia-Inducible Factor (HIF) 
Interleukin-6 (IL-6) 
Intravenous (IV) 
Iron (Fe) 
Iron Deficiency (ID) 
Iron Deficiency Anemia; IDA 
Iron Deficient Non-Anemia (IDNA) 
Live High, Train Low (LHTL) 
Low Carbohydrate, High Fat (LCHF) 
Low Energy Availability (LEA) 
Luteinising Hormone (LH),  
Maximal Oxygen Uptake (VO2max) 
Messenger RiboNucleic Acid (mRNA) 
Oral Contraceptive Cycle (OCC) 
Oral Contraceptive Pill (OCP) 
Recommended Dietary Intake (RDI) 
Relative Energy Deficiency in Sport (RED-S) 
Soluble Transferrin Receptor (sTfR) 
Transferrin Receptor (TfR) 
Transferrin Receptor-2 (TfR-2) 
Velocity at Peak Oxygen Uptake (vVO2peak) 
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Introduction  
Iron is a fundamental mineral used by the body for numerous processes such as oxygen 
transport and energy production at a cellular level (Beard 2001). Clearly, these processes are 
imperative in the support of athletic pursuit, hence, the provision, utilisation and storage of iron 
is extremely important to an athlete. Despite the biological importance, iron deficiency (ID) is 
a widely reported issue in athlete populations, with the documented prevalence reported at ~15-
35% of female and ~3-11% of male athletes (Fallon 2008, 2004; Malczewska et al. 2001; Parks 
et al. 2017). However, smaller cohort studies report higher rates of compromised iron stores 
across a variety of sports settings, with the prevalence reported as >50% in female, and up to 
30% in male athletes (Koehler et al. 2012, Tan et al., 2012). 
Of note, female athletes tend to experience a greater incidence of ID (Beard and Tobin 
2000), potentially a result of increased iron demand to account for menses (Pedlar et al. 2018). 
However, low energy intake, vegetarian diets and endurance exercise have also been proposed 
as potential factors impacting both male and female athletes’ iron stores (Castell et al. 2018). 
The symptoms of compromised iron status include lethargy, fatigue and negative mood states 
(Pasricha et al. 2010; Patterson et al. 2001; Nielsen and Nachtigall 1998), with more severe 
cases (i.e. iron deficiency anemia; IDA) also compromising work capacity (Woodson et al. 
1978). Such symptoms may impact the athlete’s ability to train appropriately and to produce 
competitive performances (Garvican et al. 2011). Consequently, it is important that the iron 
status of an athlete is routinely monitored, and that appropriate action is taken should correction 
of a deficiency be required. However, to assess an athlete’s iron status, and to determine an 
appropriate course of action, an understanding of the mechanisms that influence iron absorption 
is needed, since contemporary research has established a clear link between iron regulation and 
exercise. Furthermore, numerous research papers have explored the impact of diet, training and 
environmental stress on an athletes iron status over the past decade, with many 
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recommendations proposed for consideration. Therefore, this review will attempt to summarise 
the current state of play with respect to the aforementioned factors of interest, drawing 
conclusions and recommendations for future work in this area. 
 
How do we define an iron deficiency in athletes? 
Debate currently exists as to the most appropriate haematological variables (and their 
cut-off values) that should be measured in the assessment of an athlete’s iron status; however, 
the reader is directed to a succinct summary of these various measures by (Clenin et al. 2015). 
Despite a plethora of variables available to practitioners, the current (minimum) routine clinical 
assessment of ID includes analysis of the blood markers; ferritin, hemoglobin concentration 
(Hb), and transferrin saturation. In an attempt to classify the various stages of ID using these 
three hematological variables, Peeling et al. (2007) proposed the following for athletic 
populations: 
• Stage 1 - Iron deficiency (ID): Iron stores in the bone marrow, liver, and spleen are depleted 
(ferritin <35 μg/L, Hb >115 g/L, transferrin saturation >16%). 
• Stage 2 - Iron-deficient non-anemia (IDNA): Erythropoiesis diminishes as the iron supply 
to the erythroid marrow is reduced (ferritin <20 μg/L, Hb >115 g/L, transferrin saturation 
<16%). 
• Stage 3 - Iron-deficient anemia (IDA): Hb production falls, resulting in anemia (ferritin 
<12 μg/L, Hb <115 g/L, transferrin saturation < 16%).   
Additionally, serum soluble transferrin receptor (sTfR) levels of 2.5 mg/L could be 
considered a reasonable threshold for identification of IDA (Koulaouzidis et al. 2009). Of note, 
it appears that depleted iron stores (Stage 1) may have a minimal impact on physical 
performance; however, early correction of iron depletion is likely to prevent the issue from 
further progressing into Stages 2 and 3. For example, despite unchanged Hb concentration in 
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IDNA, training and performance outcomes may be compromised (DellaValle and Haas, 2011). 
Furthermore, Garvican-Lewis et al (2016a) reported that supplementing athletes with low pre-
altitude iron stores (<35 µg/L) with 210 mg supplemental iron per day over 3 weeks of 
moderate altitude exposure was associated with an increased hematological response compared 
to no supplementation; suggesting an essential role of iron in the adaptation process. 
Regardless, as noted by Clenin et al. (2015), a number of limitations are associated with the 
use of ferritin as a marker of iron status, such as its role as an acute phase protein, and the fact 
that ferritin levels are increased during periods of inflammation and after intensive exercise. 
Furthermore, measures of Hb are also affected by shifts in plasma volume, which when 
unaccounted for, may present issues such as pseudo-anaemia (see Bartsch et al. 1998): also 
commonly referred as sports anaemia (Sim et al. 2013), which does not appear to have any 
negative effects on performance. Considering training and/or heat adaptions can induce 
hypervolemia (Taylor. 2014; Voss et al. 2014), these factors should be considered to avoid 
underestimating the concentrations of plasma iron and red cell parameters. Additionally, blood 
collection standardisation is imperative prior to assessing an athlete’s iron status, and 
consideration must be given to the time of day, the hydration state of the athlete, and their prior 
activity levels leading into the blood assessment (Castell et al. 2018). Of note, muscle damaging 
exercise (e.g. eccentric) should not be performed in the 2-3 days prior to the assessment, since 
this type of activity can induce high levels of systemic inflammation (Peake et al., 2005), which 
may impact on the blood picture captured. Ultimately, blood screening for such purposes 
should be collected in the morning, with the athlete in a rested (i.e. 24+ h post-training) and 
hydrated state (preferably assessed via waking urinary specific gravity of <1.025; Armstrong 
et al., 2010) after an overnight fast (Figure 1).  
 
 
7 
This is a post-peer-review, pre-copyedit version of an article published in European Journal of Applied 
Physiology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00421-019-04157-y 
 
 
What are the contributing factors to iron deficiency in athlete populations? 
Given the high incidence of ID reported in athletes, it is likely that exercise, and/or 
dietary/energy availability, can influence iron metabolism in this population. Previous reviews 
exploring the underlying mechanisms of iron deficiency in athlete populations have considered 
prospects such as hemolysis exacerbated by ground impact forces (e.g. foot strike; Telford et 
al. 2003) and muscle contraction (e.g. eccentric muscle damaging exercise; Theodorou et al. 
2010), hematuria, gastro-intestinal (GI) bleeding, sweating, and inflammatory/iron regulatory 
hormone (hepcidin) responses (for review see Peeling et al. 2008). Over the past decade, a 
strong focus of the literature has been placed on this latter mechanism, with numerous papers 
showing that exercise has a transient impact on increasing levels of the master iron regulatory 
hormone, hepcidin (for 3-6 h post-exercise); likely a result of the well-documented exercise-
induced inflammatory response and associated increases in the cytokine interleukin-6 (IL-6) 
(Peeling et al. 2008; Roecker et al. 2005; Newlin et al. 2012). Increases in hepcidin activity 
result in a decrease in iron absorption and recycling from the gut and scavenging macrophages, 
respectively. As such, it is likely that there exists a transient window of altered iron metabolism 
after exercise where nutrition strategies could be exploited to manipulate the outcome (i.e., 
strategic feeding times to avoid the window of decreased iron absorption). Regardless, it is 
understood that the function of hepcidin is homeostatic in nature, and therefore, it has been 
noted that the hepcidin response to exercise is attenuated in iron deficient athletes (Peeling et 
al. 2014; Peeling et al. 2017), likely a result of the body signalling an increased iron need. The 
problem exists that exercise-induced elevations in the hormone response are evident in athletes 
with ‘healthy’ iron stores, including those that present with values at the borderline of the 
abovementioned cut-off values (i.e. ferritin 30 µg/L). Therefore, athletes that tend to sit on the 
verge of having compromised iron stores seem to be in a vicious cycle of being unable to ‘get 
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on top’ of their iron status. As such, strategies to rapidly increase iron stores may be required 
to overcome this issue (discussed further in the supplement strategies section below). 
In addition to these core mechanisms, there is also a likely link to the Relative Energy 
Deficiency in Sport (RED-S) concept (Mountjoy et al. 2014), whereby overall low energy 
availability (LEA) and energy intake in athlete populations may relate to either an overall 
deficit in dietary iron intake and/or dysfunction in its subsequent absorption. Such events may 
reduce an athlete’s chance of meeting the increased iron demands, where an additional ~1-2 
mg iron/day may be required to replenish exercise-related iron losses (Nielsen and Nachtigall 
1998). Finally, there exists the added burden of menstrual blood losses in female athletes 
(Pedlar et al. 2018) and the decreased iron bioavailability in vegetarian diets (Venderley and 
Campbell 2006) that can add to the cumulative effect of compromised iron stores in athlete 
populations. As such, it is essential that practitioners are aware of, and assess, the multitude of 
factors that contribute towards ID when working with athletes who struggle to maintain iron 
balance. Furthermore, future research is required to explore these interactions and the best 
approaches to improving the iron status of athletes that struggle to maintain optimal iron stores.  
 
How does iron deficiency impact athletic performance? 
Iron-dependent metabolic pathways involve (i) Hb and myoglobin for oxygen transport 
to the exercising skeletal muscle; and (ii) the oxidative production of adenosine triphosphate 
at the electron transport chain that is highly reliant on non-heme iron sulfur enzymes and heme-
containing cytochromes (Beard and Tobin 2000). Iron deficiency is typically associated with 
impaired aerobic power, with the magnitude of the expected performance reduction related to 
the severity of the ID. Specifically, aerobic performance is likely to be most severely affected 
when iron stores are depleted and Hb production is compromised (e.g. IDA; Stage 3 of ID) 
(Myhre et al. 2016). Consequently, reduced oxygen transport to the exercising skeletal muscle 
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may place higher demands on anaerobic metabolism (Gardner et al. 1977), which could 
negatively influence performance (e.g. lower blood pH, depletion of muscle glycogen). Given 
the reliance on aerobic metabolism and high prevalence of ID in endurance athletes, this 
population is often studied (Rubeor et al. 2018).  
Despite the importance of iron, supplementing iron to athletes without ID does not 
appear to improve endurance performance (Garvican et al. 2014; Powell and Tucker 1991; 
Tsalis et al. 2004). Furthermore, evidence for the negative influence that IDNA (Stage 1 and 
2) has on endurance performance is also equivocal, with both no effect and negative effects 
reported (Rubeor et al. 2018; Burden et al. 2015a). Specifically, as oxygen transport capacity 
is unchanged in IDNA (Stages 1 and 2), any negative influence that IDNA has on endurance 
performance may be associated with impaired function of oxidative enzymes and respiratory 
proteins (Haas and Brownlie 2001). However, as we cannot exclude other potential negative 
effects that IDNA has on health, preventing further declines to iron status must be prioritised. 
A combination of regular screening tests alongside dietary assessments should be scheduled 
periodically throughout the year to identify the need for iron supplementation (discussed in 
other sections). Such propositions have led research to investigate the role of iron supplements 
on endurance performance in IDNA athletes. For instance, in 165 IDNA female rowers (Hb 
>120 g/L), lower ferritin stores (<20 µg/L vs. ≥20 µg/L) was retrospectively associated (2-3 
months prior) with slower (~21 s) 2 km rowing TT ergometer performance (DellaValle and 
Haas 2011). In a follow-up randomised controlled trial conducted in a similar population (n=31, 
IDNA female rowers), despite unchanged 4 km rowing TT performance, daily iron 
supplements (100 mg/d) over 6 weeks were shown to decrease energy expenditure and increase 
energy efficiency during the TT (Dellavalle and Haas 2014). The authors hypothesised that 
physiological adaptions (e.g. increase in oxidative enzymes, red cell volume) typically 
associated with endurance training may only be maximised in the presence of adequate iron 
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stores. For example, greater iron bioavailability may favour adaptations leading to better 
exercise economy. However, such propositions remain to be confirmed by future research. 
Similar sentiments to those above were echoed in a meta-analysis reporting that iron 
supplementation in IDNA athletes could lead to improved aerobic performance (Burden et al. 
2015a). Here, Burden et al. (2015a) explored the efficacy of iron treatments (injection or oral 
supplements) on iron status and aerobic capacity (assessed by maximal oxygen uptake; VO2max) 
in IDNA individuals (12 studies, n=443, 82% female). Here, iron treatment had a large effect 
on ferritin, and a moderate effect on both Hb and VO2max. However, no improvements in 
VO2max were reported across eight studies, while the greatest changes in aerobic power were 
observed in studies with less-trained individuals (VO2max <40 mL/kg/min). Another recent 
meta-analysis (18 trials and 2 companion papers, n=1170 individuals) by Houston et al. (2018) 
reported that iron supplementation in IDNA adults (combing both trained and untrained 
populations) did not improve physical capacity (assessed by VO2max and other timed-exercise 
tests) despite improved perceived measures of fatigue. However, such findings may be 
different if only well-trained or elite endurance athletes were considered. Accordingly, Rubeor 
and colleagues concluded in their systemic review (12 studies, n=283 participants, 91% female) 
that 50% of studies found no performance improvements for IDNA athletes after iron 
supplementation (Rubeor et al. 2018). However, unlike the meta-analysis where aerobic power 
was assessed using VO2max, performance was quantified using a range of tests differing in their 
metabolic demands (e.g. shuttle run, 3000 m run, time to fatigue), which complicates the 
interpretation of results. Of note, when ferritin stores are substantially compromised (≤20 µg/L) 
in IDNA athletes, Rubeor and colleagues (2018) reported that iron supplementation can 
improve performance. Collectively, these meta-analyses highlight that a definitive relationship 
between IDNA and compromised performance remains ambiguous in elite athlete populations, 
11 
This is a post-peer-review, pre-copyedit version of an article published in European Journal of Applied 
Physiology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00421-019-04157-y 
 
although it is perhaps the bioavailability of iron (as indicated by ferritin) that is likely to be a 
contributing factor when performance decrements are evident.  
Alternatively, for IDA, the benefits of iron supplements to improve iron status and 
performance are well-documented and widely recognised. IDA is estimated to affect up to 18% 
and 7% of female and male athletes across a variety of sports (See Parks et al. 2017 for review). 
However, the extent of IDA could be higher during intense physical preparation, with 29% of 
elite female soccer players (from a single team) diagnosed with IDA six months prior to the 
FIFA Women’s World Cup (Landahl et al., 2005). Of interest, a case study of an elite female 
endurance athlete (19 years of age) presenting with anemia (ferritin 9.9 μg/L, Hb 88 g/L) found 
that an initial intramuscular injection (100 mg Fe), followed by twice daily oral supplements 
(100 mg, elemental Fe) over 15 weeks substantially improved iron status (ferritin 27.0 μg/L, 
Hb 130 g/L) (Garvican et al. 2011). Here, a marked and rapid increase in absolute hemoglobin 
mass (Hbmass; measured via the carbon monoxide rebreathing method; Schmidt and Prommer, 
2005) was recorded in the first ~2 weeks after the iron injection (389 g to 580 g) and continued 
to rise over the next 13 weeks (710 g). Improved iron status enabled the athlete to gradually 
increase her training load, which likely contributed to a 3000 m personal best run time ~8 weeks 
after iron treatment commenced. Although results from case studies cannot be generalised, this 
work highlights the benefits of a well-devised iron supplementation framework. Under similar 
scenarios, the aforementioned framework should be considered by support staff (i.e. sports 
medicine, nutrition and physiology) when dealing with athletes presenting with IDA.  
In summary, despite a lack of definitive evidence that IDNA compromises 
performance, the iron status of athletes should be monitored consistently throughout the 
training year. Early detection of low iron stores and subsequent supplementation may reverse 
(or limit) further declines in iron status (e.g. the progression to IDA), where a range of other 
negative effects (e.g. compromised immune function, lethargy, weakness) can exacerbate 
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performance declines. Furthermore, it is possible that compromised iron stores could have 
other unknown negative influences on numerous training (e.g. enzymes involved in energy 
production, muscle physiology/function) and recovery adaptions in athletes. Such prospects 
require further investigation by future work. Finally, as highlighted in Figure 1, blood 
screening needs to consider a range of factors (discussed subsequently) and should be 
performed (i) annually for athletes with no symptoms (or history of ID), or (ii) quarterly (or at 
least biannually) for ‘at risk’ individuals.  
 
Are there any sex differences relevant to iron deficiency? 
An estimated 11% of male and 35% of female athletes suffer from ID (Malczewska et 
al. 2001; Dubnov and Constantini 2004). In the general population, IDA is estimated to affect 
3-5% of women and <1% of men. For IDNA, this affects approximately 12-16% of 
premenopausal adult women and 2% of men (Looker et al. 1997). Active women are estimated 
to be twice as likely to present with IDNA compared to sedentary women (Sinclair and Hinton 
2005), with 24-47% of exercising women experiencing IDNA (Rowland 2012). In 193 elite 
young (<25 years) German athletes (mean age 16.2 years, ~50% female) across 24 different 
sports, the prevalence of low ferritin (<35 ug/L) was almost double in females compared to 
males (57% vs. 31%) (Koehler et al. 2012). However, the incidence of low Hb (<120 g/L or 
<130 g/L for females and males, respectively) was similar (6.2% vs 7.3%). Although sex-
specific cut-points for biomarkers related to ID have been proposed (Looker et al. 1997), such 
methods have been met with criticism. Specifically, as current practice used to establish 
reference ranges (for serum ferritin, Hb and transferrin saturation) for women contained a large 
proportion of individuals with suboptimal iron status from the general population, the lower 
limits may be set too low (Rushton et al. 2001). Therefore, the universal cut-points established 
in the iron deficiency definition section above, are generally used for athlete populations. 
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With the aforementioned guidelines in mind, IDA as defined by Dubnov and 
Constantini (2004) (ferritin <12 μg/L, transferrin saturation <16%) was observed among 7% 
of elite Basketball players (n=103, 64% male). Of the IDA athletes, 3% were male and 14% 
were female. These findings highlight the frequency of poor iron status in athletic populations, 
which may be related to a combination of factors including: (i) the aforementioned exercise-
induced mechanisms; (ii) inadequate dietary iron and/or energy intake; (iii) an influence of sex 
hormones on iron metabolism; and (iv) menses. For example, in regularly menstruating 
women, ~30-50 mL of blood is lost during menses (Dasharathy et al. 2012), with ~40 mL of 
blood resulting in an average loss of 1.6 mg of iron (Jacob and Blanche, 1965). Of concern, 
consecutive menstrual blood loss of greater than 60 mL can compromise iron stores (Andrade 
et al. 1991). Given the differences in sex hormones between males and females, this section 
will focus on the interaction between sex hormones, hepcidin and iron parameters that may 
contribute towards impaired iron metabolism. 
The predominant circulating gonadal sex steroid hormones after puberty are androgens 
in males and oestrogens in females (Sims and Heather 2018). Both testosterone and oestrogen 
can influence iron metabolism via their suppressive effects on the hepcidin-ferroportin axis 
(Bachman et al. 2010; Bachman et al. 2013; Hou et al. 2012; Yang et al. 2012). For athletes, it 
is possible that high training loads may alter an individual’s hormonal profile (Warren and 
Perlroth 2001), thereby suppressing gonadotrophin-releasing hormone (GnRH); a precursor for 
sex hormones. In women, this can lead to suppressed luteinising hormone (LH), follicle 
stimulating hormone (FSH; to a lesser extent) and consequently oestrogen. Such events likely 
contribute to secondary amenorrhea, which has previously been reported in recreational 
runners (De Souza et al. 1998). 
Few studies to date have investigated the specific effects of sex hormones such as 
oestrogen, progesterone and testosterone on hepcidin and iron status in exercising populations. 
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Of these hormones, only the role of testosterone is well-established in erythropoiesis. For 
example, in young strength-trained healthy males (n=12), weekly testosterone injections (600 
mg) resulted in a ~10% increase in Hb concentration over 20 weeks (Bhasin et al. 2001). 
Potential mechanisms including erythropoietin (EPO) secretion and the stimulation of 
erythroid progenitor cells have been proposed (Moriyama and Fisher 1975). An investigation 
in males of varying ages (aged 19–35 years, n=53; 59–75 years, n=56) reported that 
testosterone enanthate supplementation (using a range of doses 25, 50, 125, 300, and 600 mg) 
over 20 weeks, suppressed basal serum hepcidin concentration by more than 50% (Bachman 
et al. 2010). In younger men (19-35 years), hepcidin suppression was more pronounced, while 
appearing dose-dependent in older individuals (59-75 years). The proposed mechanisms for 
hepcidin down-regulation by testosterone appears multifactorial, including its stimulatory 
effect on erythropoiesis, modulation of bone morphogenetic protein signalling by the androgen 
receptor, and alterations in epidermal growth factor receptor signalling (Li et al. 2016; Guo et 
al. 2013; Latour et al. 2014). Lower circulating (~40%) and production rates of testosterone 
(~20-30%) resulting from altered hypothalamic-pituitary-testicular axis has been demonstrated 
in endurance-trained men compared to age-matched sedentary controls (Hackney et al. 2003). 
Unsurprisingly, endurance exercise completed over extended periods has also been implicated 
with lower circulating testosterone levels in men (Hackney 1996). Albeit an extreme example 
of acute endurance exercise, testosterone levels were reduced by ~58% in 38 trained males 
(aged ~32 years) after completing an Ironman triathlon race (swim 3.8 km, cycle 180 km and 
run 42.2 km) (Ginsburg et al. 2001). Comparable findings have also been reported after less 
demanding exercise, as reviewed previously (Hackney 2001). Consequently, chronic 
suppression of testosterone may be linked to higher hepcidin levels in male athletes, potentially 
impairing iron regulation, and thereby helping to explain the incidence of ID among this sex. 
In women, although lower levels of testosterone are present, its importance in iron metabolism 
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should not be ignored. For example, higher testosterone levels have been associated with lower 
risk for anemia in both healthy older women (n=509) and men (n=396) (Ferrucci et al. 2006). 
Of note, the primary female sex hormones oestrogen and progesterone (and their synthetic 
forms oestradiol and progestogens) have been implicated in hepcidin and iron regulation (Sim 
et al. 2014). 
Currently, evidence exists for oestradiol supplementation to down-regulate hepcidin 
production (Hou et al. 2012; Yang et al. 2012). Specifically, a link between oestrogen and 
hepcidin mRNA in mice has been uncovered, where oestrogen deficiency resulted in lower 
iron stores (in the liver and spleen) and higher transcription of hepcidin mRNA (Hou et al. 
2012). Another investigation examined the relationship between oestrogen and hepcidin in 
women undertaking in-vitro fertilisation treatment who had their oestrogen suppressed using 
buserelin (GnRH agonist) (Lehtihet et al. 2016). In this study, when a FSH injection was 
provided to stimulate oestrogen production, hepcidin levels decreased by 40% (median 
hepcidin: 4.85–1.43 ng/mL). These results indicate that large amounts of endogenous oestrogen 
can suppress basal hepcidin levels. When examining synthetic sex hormones, positive effects 
of an oral contraceptive pill (OCP) use on iron status have been reported; as OCP users have 
higher serum ferritin, iron, total iron binding capacity and lower menstrual blood loss (~50%) 
compared to non-users (Frassinelli-Gunderson et al. 1985; Larsson et al. 1992). Evidence also 
exists that after commencing with OCP use, ferritin increases (~21-29%) in women with poor 
iron stores (ferritin <10 μg/L) (Larsson et al. 1992). 
Although ID is often studied in female athlete populations, the interaction of the 
aforementioned sex hormones with hepcidin and iron metabolism remain unclear. For example, 
besides an inverse link between progesterone and IL-6 (a primary mediator of hepcidin) 
(Angstwurm et al. 1997), relatively little is known about the potential role of progesterone (and 
its synthetic form progestogens) on iron metabolism. To our knowledge, only one study has 
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examined the role of oestradiol in combination with progestogens for their acute effects on 
hepcidin and iron metabolism in exercising young women (Sim et al. 2015). In that study, 10 
active females on OCP performed two separate 40 min run trials at 75% of the velocity attained 
at peak oxygen uptake (vVO2peak) during specific phases of the oral contraceptive cycle (OCC): 
(a) Day 2–4, representing a hormone-free withdrawal period (D-0); (b) Day 12–14, 
representing the end of the first week of active hormone therapy (D+7). Exercise performed 
during the different phases (D-0 vs. D+7) did not alter exercise-induced IL-6 or hepcidin 
production. Specifically, serum hepcidin concentration was significantly elevated 3 h post-
exercise in both trials. Of interest, serum iron remained significantly elevated 3 h post-exercise 
as compared to baseline only during D−0 (not D+7). Of note, higher oestradiol levels are 
hypothesised to reduce oxidative stress (Stirone et al. 2005), which is known to exacerbate 
hemolysis (indicated by serum iron), thereby likely explaining why serum iron levels return to 
baseline by 3 h post-exercise at D+7, but not D−0.  
Similar basal serum iron, hepcidin, IL-6 and transferrin saturation levels have also been 
reported during different phases of an OCC (e.g. D-0 vs. D+7) in young active women (Sim et 
al. 2017). Only serum ferritin was significantly higher at D+7 compared to D-0 (69.4 vs. 61.1 
µg/L), suggesting that a combination of oestradiol and/or progestogens from the OCP can 
influence iron stores. Considering the high prevalence of ID in female athletes and active 
women, numerous questions remain regarding the potential interaction between oestrogen, 
progesterone and iron metabolism. Since favourable links between oestradiol (or oestrogen) 
and iron regulation exist, future studies should examine both the acute post-exercise hepcidin 
response and its longitudinal influence on markers of iron status in OCP users vs non-users 
(including different phases of the menstrual cycle). This work should also consider the 
influence that sex hormones might have on menstrual blood loss and oxidative stress-induced 
hemolysis, and the implications for exercise-induced ID. 
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What is the impact of diet on the iron status of athletes? 
The current recommended dietary intake (RDI) for elemental iron is 8 mg for males 
and 18 mg for females (Trumbo et al. 2001), with the higher intake in women attributed to the 
iron losses associated with menses (McClung 2012). However, given the aforementioned 
mechanisms of iron loss that occur as a result of exercise, it is likely that athletes have a higher 
iron requirement than the general population. For instance, despite consuming iron at the RDI 
(13-18 mg/day), a block of intensified training was shown to reduce ferritin concentrations by 
25-40% in a group of international-level endurance athletes (McKay et al. 2018). This suggests 
that the current iron recommendations for the ‘general population’ may not be sufficient for 
athletes, supporting the case for athlete-specific recommendations to be developed (Thomas et 
al. 2016). 
Developing appropriate RDIs for athletes is important, since iron cannot be synthesised 
by the body and is attained solely from dietary sources, primarily in the form of wholegrain 
cereals, fish, poultry and meat. For reference, a comprehensive list of the iron content for 
various foods can be found on the United States Department of Agriculture Food Composition 
Database (USDA, 2015), while a condensed list of iron rich food has been prepared by the 
British Dietetic Association (Gill, 2017). The timing, amount and source of dietary iron, in 
combination with the overall iron composition of the diet are all important factors for 
practitioners to consider, since they collectively influence total iron absorption. For instance, 
it is well-known that heme iron sources (from meat) exhibit greater absorptive capacity (~5-
35%) than non-heme sources (~2-20%) from a single meal (Beard and Tobin 2000). 
Furthermore, the presence of various dietary components such vitamin C, meat, poultry and 
fish can enhance non-heme iron absorption, whereas substances such as polyphenols, phytates, 
or calcium, that are part of tea, coffee, whole grains, legumes and dairy products, can decrease 
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the amount of non-heme iron absorbed from a given meal (Saunders et al. 2013). With this in 
mind, it is clear that athletes should be working with trained dietitians and nutrition experts 
when planning their meal composition to optimise dietary iron absorption. 
Notwithstanding the dietary composition, it might also be considered that the 
aforementioned transient increases in hepcidin activity may require strategic thinking relevant 
to the timing of post-exercise iron intake for athletes, with impaired iron absorption likely to 
occur during the post-exercise window. However, to add another layer of complexity, hepcidin 
activity also shows a strong diurnal variation, with the lowest levels observed in the morning, 
and a steady increase reported throughout the day (Schaap et al. 2013). Therefore, it may be 
that optimal iron ingestion should occur as far away from exercise as possible, in an attempt to 
maximise its absorption, with a preference for the morning, compared to evening consumption. 
However, the impact of exercise, coupled with typically higher breakfast calcium intake, and 
the diurnal variation of hepcidin presents a logistical challenge for the elite athlete population, 
who often complete multiple training sessions on each day, and likely consume their highest 
iron containing meals in the evening, when hepcidin levels are naturally elevated. As a result, 
literature is lacking when it comes to the appropriate timing of iron consumption for the elite 
athlete population. Interestingly, recent work from our laboratory (McCormick et al., 2019) 
indicates a potential open window of opportunity if the iron is consumed within 60 min of 
completing exercise in the morning, likely a result of the iron reaching the gut within the 3-
hour period before transient hepcidin elevations take effect. However, further work is required 
to fully elucidate the prospects of such a window, and whether this strategy is applicable to 
elite-level athletes with full training schedules. 
 
What is the influence of contemporary nutritional strategies on iron regulation? 
Recent interest in iron metabolism has focused on nutritional strategies where select 
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exercise sessions are deliberately undertaken with low muscle glycogen stores, with the 
primary goal of increasing transcriptional activation of enzymes involved in carbohydrate 
(CHO) and fat oxidation, as well as greater mitochondrial biogenesis (Burke et al. 2018; Impey 
et al. 2018). While these strategies may promote endurance adaptation, they may also interfere 
with post-exercise iron metabolism. Given IL-6’s role as an energy sensor for contracting 
muscle, this explains augmented post-exercise IL-6 concentrations when training under 
conditions of low CHO availability (Hennigar et al. 2017). Furthermore, as IL-6 is a key 
cytokine involved in the up-regulation of hepcidin levels post-exercise, training with low 
muscle glycogen stores may also amplify hepcidin levels following exercise. Such events 
potentially prolong the post-exercise period of impaired iron absorption and metabolism.  
Investigations of acute CHO supplementation have found minimal influence on iron-
regulation (Dahlquist et al. 2017; Robson-Ansley et al. 2011; Sim et al. 2012), however, it 
appears diet-training strategies that target depleting muscle glycogen stores may have a greater 
impact. For instance, Badenhorst et al. (2015) demonstrated both IL-6 and hepcidin 
concentrations were elevated in response to exercise after 24 h of a low (3 g/kg), compared to 
high CHO (8 g/kg) diet. Interestingly, when this diet was extended across 7 days, no differences 
in iron-regulation were evident (Badenhorst et al. 2016). However, the programing of a rest 
day prior to the exercise test on day 7, combined with the increased protein consumption in the 
low CHO condition likely minimised any differences in muscle glycogen stores between 
dietary conditions. Further research in this area, using elite athletes adhering to a low CHO 
high fat (LCHF) diet for 3 weeks (<50 g CHO / day), observed increased IL-6 and hepcidin 
levels (3 h post-exercise) following a 2 h bout of race walking, compared to athletes consuming 
a CHO-rich diet (McKay et al. 2018). However, differences in the baseline iron status of the 
athletes in this investigation may have been a confounding factor when interpreting changes to 
hepcidin concentrations (McKay et al. 2019; Peeling et al. 2014). In light of these recent 
20 
This is a post-peer-review, pre-copyedit version of an article published in European Journal of Applied 
Physiology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00421-019-04157-y 
 
findings, it is evident that the macronutrient composition of an athletes’ diet may impact on 
post-exercise iron metabolism. As a result, we currently suggest that the use of nutritional 
approaches that restrict CHO should be carefully considered, particularly for athletes with 
increased iron requirements (e.g. growth, altitude, females or endurance athletes) or those 
consuming low dietary iron intakes (e.g. vegetarians, weight category athletes). Finally, a 
greater understanding of the relationship between the dietary macronutrient composition, 
current iron status, inflammatory responses to exercise, and subsequent hepcidin activity is 
warranted to further our understanding of the true influence of contemporary nutritional 
strategies on iron metabolism. 
 
Is there an impact of overall energy availability?  
Low energy availability occurs in athletes when a mismatch between energy intake and 
energy expenditure is evident (Loucks et al. 2011). RED-S is an umbrella term used to describe 
the health and performance consequences associated with LEA in athletes. Of note, ID is an 
associated haematological outcome of RED-S (Mountjoy et al. 2018), with a retrospective 
questionnaire-based investigation of 1000 female athletes reporting that LEA was associated 
with greater risk (64%) for hematologic dysfunction (characterised by a history of anaemia, 
low Hb, iron or ferritin) (Ackerman et al. 2018). Recent work supports these findings, with 
significantly higher Hbmass (7.9%) recorded in eumenorrheic (n=22) versus amenorrheic (n=13) 
elite females runners; indicating the importance of long-term energy availability for relevant 
health outcomes (Heikura et al. 2018). One explanation is that athletes with LEA are in energy 
deficit and are not reaching the RDI for dietary iron. A typical Western diet is shown to provide 
~6 mg of iron per ~4200 kJ (Beard and Tobin 2000). Therefore, reduced energy intake may 
result in low dietary iron consumption, subsequently having negative implications for an 
athlete’s iron status. Additionally, many negative health outcomes associated with RED-S can 
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be exacerbated by ID. For example, low iron stores are known to perturb thyroid function, 
decrease appetite and impair metabolic efficiency; alterations of which can lead to reduced 
energy intake, increased energy expenditure and potentially contribute to LEA in athletes 
(Petkus et al. 2017). Therefore, it appears that ID can be a negative consequence of LEA; 
however, ID itself may also amplify some of the other undesirable outcomes (e.g. weakness 
and extreme fatigue) associated with RED-S. 
With this in mind, studies directly linking LEA and ID are lacking, and further research 
is required to understand this relationship. Perhaps, low iron stores may be an early indication 
of LEA and supplementation should be considered to minimise other health consequences 
associated with RED-S. However, first and foremost, targeted nutrition counselling focusing 
on adequate energy and nutrient intake should be emphasised to correct energy availability. 
Notably, future work examining the implications of RED-S and/or LEA on hepcidin expression 
and iron metabolism is warranted. Such work could provide direct evidence for the mechanistic 
interaction between RED-S and ID. Finally, since the physiology of elite athletes, in 
combination with high training loads, make such populations unique, the inclusion of healthy 
recreationally active controls as part of this work should be considered. 
 
What are the strategies to address an iron deficiency? 
Given the increased iron demand placed on an athlete, an adequate exogenous iron 
supply is imperative to maintaining appropriate iron levels. With the inability to endogenously 
replace taxed iron stores, supplemental sources of iron are an important consideration for 
athletes and their support team. When faced with an ID, there are three primary strategies for 
iron supplementation (Castell et al. 2018); these include (a) increasing dietary iron intake, (b) 
supplemental oral iron, or (c) parenteral iron administration. In determining the most 
appropriate strategy, the athlete and support team must first consider the severity of the ID, the 
22 
This is a post-peer-review, pre-copyedit version of an article published in European Journal of Applied 
Physiology. The final authenticated version is available online at: http://dx.doi.org/10.1007/s00421-019-04157-y 
 
typical individual response to a given supplement preparation, the time required for iron 
repletion via the strategy chosen (generally in context of the training phase), and of course, any 
legalities of supplement choice in respect to the sport’s governing body and anti-doping 
authority. Furthermore, it is important to ascertain and treat any potential causes of ID (e.g. 
underlying pathophysiology), as this could facilitate the efficacy of iron supplementation and 
prevent future reoccurrence. 
The initial and most conservative strategy to approaching an ID is for a full dietary 
assessment by a qualified sports dietitian, with a subsequent eating plan that focuses on 
increasing dietary iron intake from food. Considering the aforementioned superior absorption 
of heme compared to non-heme iron, vegetarian athletes presenting with compromised iron 
stores are a more complex case when approaching the issue via this strategy. An additional 
complexity when considering diet as a primary means to address an ID are the concurrent 
absorption enhancers and/or inhibitors that may be consumed with the iron source (Saunders 
et al. 2013). As such, careful planning is required when manipulating the diet to increase iron 
absorption, and factors other than total iron intake must be considered. 
The second strategy to addressing compromised iron stores requires the use of oral iron 
supplements, commonly consumed as either tablet or liquid preparations. Oral iron 
supplements are generally provided in the ferrous form (fumarate, sulphate or gluconate), 
however, ferric preparations are also available; although the GI tolerance for ferric iron 
supplements appears low (Hoffman et al. 2000). Of note, in a comparative review of ferrous 
versus ferric oral iron formulations (Santiago 2012), slow-release ferrous sulphate preparations 
remained the established and standard treatment of ID, resulting from their acceptable 
tolerability, adequate bioavailability and overall efficacy of effect. However, it should be noted 
that a generally high incidence of GI-disturbance from oral iron supplementation is commonly 
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reported (Tolkien et al. 2015); and in such cases, consideration of iron polymaltose preparations 
or using enteric tablet coating may be helpful. 
Generally, the overall response to oral iron supplementation in athlete cohorts appears 
positive (40-80% increases to ferritin) when consumed over an 8-12 week time frame, utilising 
doses of ~100 mg per day (Garvican et al. 2014; Dawson et al. 2006). However, alternate day 
supplementation may increase the efficacy of effect via an improvement in the fractional 
absorption of iron from a given dose, which over time, results in a greater cumulative response 
(Stoffel et al. 2017). Such regimens, in combination with iron absorption enhancers such as 
vitamin-C, should be considered. Furthermore, under extreme environmental stress (e.g., 
exposure to altitude), a greater dose of oral iron may be required to sustain iron stores and assist 
in the haematological adaptation (as discussed in detail below). 
The final method of addressing an iron deficiency comes in the form of parenteral iron 
preparations via intramuscular or intravenous (IV) administration. Previous literature has 
shown both approaches to be very effective at improving an athlete’s iron status, with 200-
400% increases in ferritin levels reported from 300-550 mg of iron delivered over a 1 to 42-
day period (Dawson et al. 2006; Garvican et al. 2014; Woods et al. 2014; Burden et al. 2015b). 
Modern advances in IV preparations (Macdougall, 2009) have increased the safety and 
accessibility of IV supplementation, with injections or infusions commonly delivered in an out-
patient setting. As such, IV administration has largely supersceded intra-muscular 
administration that is commonly associated with soreness and staining around the injecion site. 
The clear benefit of an IV supplement strategy is the speed and magnitude of the response, 
without GI upset, in comparison to the aforementioned approaches of dietary modification or 
oral supplementation. This is likely a result of such administration methods by-passing the gut 
where key issues of iron absorption exist. With this in mind, parenteral supplement methods 
may be of great importance when a situation requires rapid improvement in iron stores, or when 
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gut issues appear to render more traditional methods of iron therapy impractical and ineffective. 
Regardless, the use of these adminstration methods do come with some risks of adverse 
reactions, which may manifest as a mild rash through to anaphlyaxis (in very rare cases; 
Rampton et al. 2014).  
Also worth considering is the concept of maximising iron stores through 
supplementation during periods of lower activity (e.g. off-season). Inevitably, as training load 
and iron demands increase during the competitive season, higher iron reserves may limit the 
negative influence that exercise training has on the bioavailability of iron. In conclusion, the 
decision to undertake, and the supplement administration strategy should be made by the sports 
physician, in consultation with the support team (i.e. dietician). Furthermore, in deciding to 
pursue this avenue, care should be taken to ensure that the method of supplement delivery is 
acceptable and consistent with the sport’s governing body and the anti-doping authorities. 
 
Does iron play a significant role in adaptation to hypoxic environments?  
Prolonged (>2 week) exposure to low (1000–2000 m) and moderate (2,000–3000 m) 
simulated or terrestrial altitudes (Bärtsch et al. 2008) is associated with several hematological 
(increased Hbmass) and non-hematological adaptations (increased iron-dependent oxidative and 
glycolytic enzyme concentrations) that assist aerobic exercise performance (see Hahn and 
Gore, 2001) for a comprehensive review). The magnitude of the change in Hbmass during live 
high, train low (LHTL) altitude training depends upon the hypoxic dose (defined in kilometre 
hours (km/h) = (m/1,000) × h), and is characterised by an exponential increase, followed by an 
eventual plateau after ~4 to 5 weeks (Garvican-Lewis et al. 2016b). Although large intra- and 
inter-individual variability exists in the Hbmass response (Siebenmann et al. 2015), hypoxic 
exposure of 1000 km/h (e.g. 21 days at 2,000m) is associated with a ~3-4% increase in Hbmass. 
Of note, altitude training places a large demand on an athlete’s iron stores, since, in addition to 
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the aforementioned ~1-2 mg iron/day required to replenish exercise-related iron losses (Nielsen 
and Nachtigall 1998), altitude exposure increases erythroid iron demand by 3- to 5-fold 
(Reynafarje et al. 1959). Therefore, low iron availability during prolonged altitude exposure 
may blunt hematological adaptations (Stray-Gundersen et al. 1992; Garvican-Lewis et al. 
2018), in turn decreasing the potential performance benefits that may be gained from altitude 
exposure. 
 
How is iron metabolism regulated in hypoxia? 
Oxygen sensing and the regulation of iron metabolism during altitude exposure are 
linked by three distinct isoforms of hypoxia-inducible factor (HIF-1α, HIF-2α and HIF-3α), 
with the HIF-2α isoform stimulating EPO production (Kapitsinou et al. 2010). Continuous 
hypoxic exposure causes plasma EPO to increase within ~90 min (Rodríguez et al. 2000), 
peaking usually within 48 hours and returning to baseline levels (or below) after one week 
(Garvican et al. 2012). EPO principally acts upon receptors located on erythroid progenitor 
cells in the bone marrow, stimulating the differentiation of proerythroblasts into basophilic, 
polychromatic and orthochromatic forms. Iron supply to differentiating erythroid cells is met 
almost entirely by diferric transferrin (Leimberg et al. 2008). Proerythroblasts then enucleate 
to form reticulocytes, which are expelled into the blood plasma as mature red blood cells. These 
adaptations typically manifest as measurable changes in Hbmass after approximately 10 days 
(Garvican et al. 2012). 
Several changes in systemic iron metabolism occur to support accelerated 
erythropoiesis in hypoxia, including increased iron efflux from storage sites 
(reticuloendothelial macrophages, hepatocytes and enterocytes), increased iron transport to the 
erythron, and increased intestinal iron absorption (see Chepelev and Willmore (2011) for 
review). Hypoxic stress has been shown to strongly inhibit liver hepcidin production within 15 
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h of exposure (Ravasi et al. 2018), thereby promoting iron release from (predominantly) 
reticuloendothelial macrophages in the bone marrow to support erythropoiesis. Hepcidin 
suppression in hypoxia is not directly mediated by EPO (Canali et al. 2016); instead, the 
hormone erythroferrone (ERFE) is released by proerythroblasts and acts to suppress hepcidin 
expression (Kautz et al. 2014). Simultaneously, during early hypoxic exposure, several growth 
factors in the bone marrow (but not the spleen or liver) may also play a role in hypoxic hepcidin 
suppression (Ravasi et al. 2018). However, since these growth factors and ERFE are down-
regulated within 48 h, alternative mechanisms have been suggested to regulate the later phases 
of hepcidin suppression in hypoxia (Ravasi et al. 2018). These mechanisms include erythroid 
iron demand as indicated by the current plasma transferrin receptor-2 (TfR-2) concentration. 
TfR-2 is highly expressed by erythroblasts and involved in sensing plasma diferric transferrin 
concentration, in turn modulating EPO receptor signalling. In addition to hepcidin suppression, 
hypoxic stabilisation of HIF-2α up-regulates divalent metal transporter 1 (an iron import 
protein; DMT-1) and duodenal cytochrome b (a ferric reductase; DCytB) expression on 
duodenal enterocytes, thereby increasing intestinal iron absorption (Goetze et al. 2013) from 
~15-20% in normoxia to ~20-25% in hypoxia (Reynafarje et al. 1959). Additionally, hypoxic 
stabilisation of HIF-1α promotes increased iron transport to the erythron by increasing TfR 
expression within ~16-40 h of hypoxic exposure (Piperno et al. 2010). 
 
Are there specific iron supplementation strategies at altitude for an optimised outcome? 
Athletes need sufficient iron stores to support accelerated erythropoiesis and to 
replenish exercise-related iron losses associated with daily training during prolonged altitude 
exposure. Athletes typically receive oral iron supplements before and during altitude exposure 
to maintain iron balance (Garvican-Lewis et al. 2018). However, despite several different 
serum ferritin cut-off values being used to guide iron supplementation during altitude exposure 
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(Constantini et al. 2017; Garvican-Lewis et al. 2018; Hauser et al. 2018), the optimal iron 
supplementation strategy, including timing, dose and administration route (i.e. oral versus 
intravenous) to maximise hematological adaptations is still emerging. 
The decision to provide iron supplementation to athletes undertaking altitude exposure 
should be made by a sports physician following a review of their pre-exposure blood profile. 
Blood screening should be performed three-to six weeks before exposure, and should include 
a full blood count (but preferably Hbmass via the carbon monoxide-rebreathing method, since it 
is not affected by the plasma volume shifts that occur at altitude), iron profile (including serum 
iron, serum ferritin and transferrin saturation) and C-reactive protein assessment (reflecting 
systemic inflammation over the previous ~24-48 h). This enables the size of the red cell 
compartment, iron storage pool and the presence of inflammation, to be quantified, 
respectively. Based upon their pre-exposure serum ferritin concentration, athletes are usually 
prescribed iron supplements to avoid the development of an ID and to support erythropoiesis 
(Govus et al. 2015). On a cautionary note, pre-exposure serum ferritin concentration appears 
to be a weak predictor of Hbmass changes at altitude in individuals with otherwise healthy iron 
stores (Hauser et al. 2018; Ryan et al. 2014). Other factors, such as the rate of iron efflux from 
bone marrow and splenic macrophages, in addition to the rate of iron transport to the erythron 
(indicated by the transferrin saturation) during early adaptation, likely exert a greater influence 
on the resulting haematological adaptation. In practical terms, the adequacy of an athlete’s iron 
storage pool for a prolonged altitude sojourn likely depends both on the overall hypoxic dose 
(Garvican-Lewis et al. 2016b) (with larger hypoxic doses, such as longer duration and higher 
elevations requiring more iron owing to the potentially greater hematological response), the 
volume of training performed, and the preparation time available. 
Of note, oral iron supplements remain the most common form of iron used for altitude 
training, and are typically administered daily for two to six weeks before, and throughout 
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exposure, in order to ensure that athletes can maintain a sufficient iron balance over time. In a 
retrospective analysis of athletes undertaking simulated LHTL altitude training, Hbmass was 
improved even in athletes with low pre-exposure iron stores (considered by the authors as 
serum ferritin: <35 μg/L) who were supplemented with oral iron supplements for two weeks 
before, and for the duration of the altitude exposure (Govus et al. 2015). In fact, athletes with 
a pre-exposure serum ferritin concentration <20 μg/L, who were supplemented with 210 mg 
elemental iron/day, not only increased their Hbmass (+4.0%), but also increased their iron stores, 
indicating that the oral iron dose exceeded bone marrow iron uptake. As such, hypoxic-
mediated changes in iron metabolism during altitude exposure (e.g. suppression of hepcidin, 
increased iron absorption, transport and the mobilisation of iron from storage sites) may 
improve the efficacy of oral iron supplementation; assisting in the hematological adaptation to 
the environmental stress. 
The timing and dose of oral iron supplements during prolonged altitude exposure may 
affect intestinal iron absorption and subsequent incorporation by the erythron, in turn affecting 
haematological adaptations to prolonged altitude exposure. For example, Hall et al. (2018) 
found that a single nightly dose of oral iron supplement (200 mg elemental iron/d delivered 
nightly), rather than a split dose of oral iron supplement (2 × 100 mg elemental iron/day 
delivered in the morning and evening, respectively), was associated with a higher Hbmass 
response in athletes exposed to 2106 m terrestrial altitude for ~3 weeks. Of note, both doses 
allowed athletes to maintain or increase their pre-exposure serum ferritin concentration. 
However, GI discomfort, a common side effect of oral iron supplements, was higher in the 
single compared with the split dose group; decreasing by the third week of exposure. As such, 
a single dose of oral iron supplement may be superior to a split dose (of the same concentration) 
during prolonged altitude exposure to maximise Hbmass adaptations. 
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In contrast to oral iron supplements, IV iron preparations allow athletes to rapidly 
increase their iron stores and are not associated with GI discomfort, instead delivering iron 
directly into the splenic macrophages (Girelli et al. 2018). We recently reported that both IV 
iron supplementation and oral iron supplementation augment ΔHbmass (%) in endurance-trained 
athletes who undertook 3 weeks of simulated LHTL altitude training (Garvican-Lewis et al. 
2018). Notably, the ΔHbmass (%) was not greater than the coefficient of variation for the CO 
rebreathing method (1.5%) in the non-iron supplemented group. Of note, Hbmass decay was less 
rapid post-altitude exposure in the IV group as compared to the oral group. Therefore, IV iron 
supplementation may be useful to prepare athletes for prolonged sojourns at moderate altitudes 
(~2000-3000 m) when athletes have little time to adequately prepare for the altitude exposure. 
However, given the greater logistical (i.e. medical assistance required), financial (IV iron is 
more expensive than oral iron) and ethical concerns (some sports have a “no needle policy”) 
associated with IV iron supplements, oral iron supplementation should be considered as the 
first choice iron supplementation strategy to prepare athletes for prolonged altitude sojourns. 
 
Summary 
This review summarises evidence regarding the regulation and increased demands of 
iron in athletic populations. We have covered key topics related to athletes’ iron regulation 
including (i) the effects and severity of ID on performance; (ii) sex and the implications of sex 
hormones on iron parameters; (iii) diet, including macronutrient manipulation and RED-S; and 
finally, (v) the demands and influence of hypoxia as part of altitude exposure. Collectively, we 
also highlight the multifactorial causes of exercise-induced ID and prevention strategies (e.g. 
dietary intake or supplements), and provide suggestions for future work and practical 
information that should be considered by athletes and their support staff (sports dietitians, 
physiologists and physicians). We propose that the iron status of athletes are monitored closely 
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throughout the training year, and that particular attention should be paid in situations linked 
with increased iron loss and/or demands; such as chronically high training loads and 
environmental factors (altitude), respectively. Although the influence of IDNA on athletic 
performance remains unclear, early detection of low iron stores and subsequent 
supplementation may reverse (or limit) further declines to iron status. As detailed in Figure 1, 
we propose that blood screening should be performed regularly for athletes, while also 
considering a diverse range of circumstances. On a positive note, substantial progress has been 
made in understanding the role of iron, mechanisms of its regulation, and the strategies used to 
correct a deficiency/optimise adaptation; however, continued research is required to further our 
ability to reduce the burden of an iron deficit in athlete populations. 
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Figure 1. Framework of considerations for the frequency of iron blood screening in athlete populations.  *This framework requires the expertise of trained 
professionals including sports physicians, dietitians and physiologists. #Stages of iron deficiency are defined by Peeling et al. (2007). 
Considerations and frequency of iron blood screening for athletes* 
 
Annually Biannually Quarterly 
• No history of iron deficiency 
• No history of irregular/excessive 
menses or amenorrhea 
• No reports of fatigue after extended 
rest 
• Strength/power-based sports with 
minimal endurance component 
• No iron-related dietary restrictions 
• No evidence of low energy 
availability 
• No intention to undertake hypoxic 
training in the next 12 months 
• No underlying pathology  
(e.g. coeliac or Crohn’s disease) 
• Female 
• Previous history (≥ 24 months) of 
iron depletion  (e.g. Stage 1#) 
• Previous history (≥ 24 months) of 
irregular/excessive menses 
• Intention to undertake high training 
loads especially in endurance and 
team-based sports 
• Minimal (or zero) reports of 
prolonged fatigue after extended rest 
• No iron-related dietary restrictions 
(e.g. non-vegetarian, non-vegan) 
• No evidence of low energy 
availability 
• Intention to undertake hypoxic 
training in the next 12 months 
• Any recent history (<24 months) of 
iron depletion/deficiency (Stage 1, 2 
or 3#) irrespective of sex 
• Any evidence of irregular/excessive 
menses or amenorrhea 
• High training loads in team and 
endurance-based sports 
• Reporting prolonged 
fatigue/lethargy even after extended 
rest 
• Reduced work capacity during 
training 
• Unexplained poor athletic 
performance 
• Individuals restricting sources of 
dietary iron (e.g., vegetarian and 
vegan) or overall caloric intake 
• Any evidence of low energy 
availability 
• Intention to undertake hypoxic 
training in the next 6 months  
Variables to be considered 
• Minimum: Serum ferritin, hemoglobin concentration, transferrin 
saturation 
• Desirable: Serum soluble transferrin receptor, hemoglobin mass, 
C-reactive protein 
 
 
 
Standardisation of blood collection 
• Time of day: Preferably in the morning 
• Hydration state: hydrated preferably assessed by waking urinary 
specific gravity (< 1.025) 
• Low to moderate activity in the proceeding 24 hours, including no 
muscle-damaging exercise (e.g. eccentric) in the 2-3 days prior 
• No signs of sickness or infection 
 
